EU Merger Regulation - Review of 2017 and Beyond

被引：0
作者：
Meyring, Bernd [1 ]
Hoolihan, Neil [1 ]
机构：
[1] Linklaters LLP, Brussels, Belgium
来源：
JOURNAL OF EUROPEAN COMPETITION LAW & PRACTICE | 2019年 / 10卷 / 02期
关键词：
D O I：
10.1093/jeclap/lpz008
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
[No abstract available]
引用
收藏
页码：115 / 128
页数：14
相关论文
共 36 条
  • [1] Du Pont/ICI, (1992)
  • [2] Council Regulation on the control of concentrations between undertakings ('Horizontal Guidelines, OJ C31, 5, (2004)
  • [3] Medtronic/Covidien, (2014)
  • [4] Novartis/GlaxoSmithKline Oncology Business, (2015)
  • [5] Pfizer/Hospira, (2015)
  • [6] Dow/DuPont, (2017)
  • [7] J&J/Actelion, (2017)
  • [8] Commission Notice on Remedies Acceptable under Council Regulation (EC) No 139/2004 and under Commission Regulation (EC)
  • [9] Dow/DuPont, (2017)
  • [10] Bayer/Monsanto, (2018)
1234